David G Kalergis Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David G Kalergis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David G Kalergis. David G Kalergis is Chairman and CEO in Diffusion Pharmaceuticals Inc. ($DFFN).
Latest Insider Trading Transactions of David G Kalergis
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 30 2020 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.46 | 262,900 | 120,934 | 262,900 | |
Jan 04 2018 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 1.18 | 55,000 | 64,900 | 55,000 | |
May 12 2017 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 2.95 | 41,000 | 120,950 | 41,000 | |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 2.74 | 105,000 | 287,700 | 105,000 | |
May 20 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.96 | 204,167 | 196,000 | 204,167 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.55 | 331,595 | 182,377 | 331,595 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.42 | 127,843 | 53,694 | 127,843 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.62 | 182,632 | 113,232 | 182,632 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.35 | 127,843 | 44,745 | 127,843 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.22 | 273,949 | 60,269 | 273,949 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.22 | 91,316 | 20,090 | 91,316 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.22 | 295,865 | 65,090 | 295,865 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Grant | A | 0.00 | 215,506 | 0 | 215,506 | 0 to 215.5 K |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Grant | A | 0.00 | 1,069,216 | 0 | 1,069,216 | 0 to 1.1 M |
Page: 1